Invesco Nasdaq Biotechnology ETF (IBBQ) price, chart and fund profile
Price chart
Fund profile
IBBQ tracks a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ.
- Issuer
- Invesco Capital Management LLC
- Industry
- Healthcare
- Inception
- Jun 11, 2021
- Assets under management
- $96.3M
- Expense ratio
- 0.19%
- Net asset value
- $35.41
- NAV as of
- Aug 28, 2026
- Leverage
- 1×
- Fund page
- www.invesco.com↗
Frequently asked questions
What is Invesco Nasdaq Biotechnology ETF (IBBQ)?
IBBQ tracks a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ.
What is IBBQ's expense ratio?
Invesco Nasdaq Biotechnology ETF charges an annual expense ratio of 0.19%. The fund is issued by Invesco Capital Management LLC.
How large is IBBQ?
Invesco Nasdaq Biotechnology ETF manages $96.3M in assets and has traded since Jun 11, 2021.
How do I buy shares of Invesco Nasdaq Biotechnology ETF (IBBQ)?
IBBQ trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web dashboard at portal.lighthorse.io, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.